| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2013PLoSO...880027D |
| P356 | DOI | 10.1371/JOURNAL.PONE.0080027 |
| P8608 | Fatcat ID | release_7pvxqlz4arhyrgtz5ybwtqbg7y |
| P932 | PMC publication ID | 3817113 |
| P698 | PubMed publication ID | 24224032 |
| P5875 | ResearchGate publication ID | 258504450 |
| P50 | author | Paul Schaeffer | Q55474099 |
| P2093 | author name string | Françoise Bono | |
| Nathalie Delesque-Touchard | |||
| Frédérique Dol-Gleizes | |||
| Anne-Laure Nestor | |||
| Anne-Marie Marès | |||
| P2860 | cites work | Inhibition of tumor angiogenesis and growth by a small-molecule multi-FGF receptor blocker with allosteric properties | Q24338659 |
| Concept of vulnerable/unstable plaque | Q27687028 | ||
| Inhibition of fibroblast growth factor receptor signaling attenuates atherosclerosis in apolipoprotein E-deficient mice. | Q50734228 | ||
| DNA vaccination against VEGF receptor 2 reduces atherosclerosis in LDL receptor-deficient mice. | Q51766388 | ||
| Antisense inhibition of basic fibroblast growth factor induces apoptosis in vascular smooth muscle cells. | Q52519666 | ||
| Endothelial FGF receptor signaling accelerates atherosclerosis | Q54406233 | ||
| Acidic and basic fibroblast growth factors in adult rat heart myocytes. Localization, regulation in culture, and effects on DNA synthesis | Q56428111 | ||
| Smooth muscle cell abundance and fibroblast growth factors in coronary lesions of patients with nonfatal unstable angina. A clue to the mechanism of transformation from the stable to the unstable clinical state | Q71601194 | ||
| Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors | Q27737008 | ||
| Design, synthesis, and evaluations of substituted 3-[(3- or 4-carboxyethylpyrrol-2-yl)methylidenyl]indolin-2-ones as inhibitors of VEGF, FGF, and PDGF receptor tyrosine kinases | Q28377765 | ||
| Kinetic PCR Analysis: Real-time Monitoring of DNA Amplification Reactions | Q29395822 | ||
| Inflammation, atherosclerosis, and coronary artery disease | Q29547232 | ||
| Mouse models of arteriosclerosis: from arterial injuries to vascular grafts | Q30481132 | ||
| Distinct patterns of expression of fibroblast growth factors and their receptors in human atheroma and nonatherosclerotic arteries. Association of acidic FGF with plaque microvessels and macrophages | Q33908328 | ||
| Chemokines, leukocytes, and atherosclerosis | Q34005747 | ||
| Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor | Q34617842 | ||
| Progression of atheroma: a struggle between death and procreation | Q34858516 | ||
| Arterial smooth muscle cell heterogeneity: implications for atherosclerosis and restenosis development | Q35195495 | ||
| Mouse model of venous bypass graft arteriosclerosis | Q35753478 | ||
| Inflammation and restenosis after percutaneous coronary interventions | Q35903106 | ||
| Vessel wall apoptosis and atherosclerotic plaque instability. | Q36062157 | ||
| Platelets and chemokines in atherosclerosis: partners in crime | Q36085380 | ||
| Atherothrombosis and high-risk plaque: part I: evolving concepts | Q36259704 | ||
| Role of angiogenesis in cardiovascular disease: a critical appraisal. | Q36261464 | ||
| Angiogenesis in atherogenesis | Q36516079 | ||
| Novel concepts in atherogenesis: angiogenesis and hypoxia in atherosclerosis | Q37421663 | ||
| Biological mechanisms of microvessel formation in advanced atherosclerosis: the big five | Q38078613 | ||
| Basic fibroblast growth factor (bFGF, FGF-2) potentiates leukocyte recruitment to inflammation by enhancing endothelial adhesion molecule expression | Q38622783 | ||
| Molecular bases of the acute coronary syndromes | Q40530238 | ||
| Transcriptional regulation of FGF-2 gene expression in cardiac myocytes | Q42462063 | ||
| Angiotensin AT1 receptor antagonist irbesartan decreases lesion size, chemokine expression, and macrophage accumulation in apolipoprotein E-deficient mice | Q42656141 | ||
| Fibroblast growth factor receptor-1 is essential for in vitro cardiomyocyte development | Q44534256 | ||
| Lesion progression in apoE-deficient mice: implication of chemokines and effect of the AT1 angiotensin II receptor antagonist irbesartan | Q44723443 | ||
| VEGF-R2 and neuropilin-1 are involved in VEGF-A-induced differentiation of human bone marrow progenitor cells | Q44979291 | ||
| Inhibition of accelerated graft arteriosclerosis by gene transfer of soluble fibroblast growth factor receptor-1 in rat aortic transplants. | Q47794548 | ||
| Vaccination against VEGFR2 attenuates initiation and progression of atherosclerosis | Q50070810 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | atherosclerosis | Q12252367 |
| P304 | page(s) | e80027 | |
| P577 | publication date | 2013-01-01 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | A new synthetic FGF receptor antagonist inhibits arteriosclerosis in a mouse vein graft model and atherosclerosis in apolipoprotein E-deficient mice | |
| P478 | volume | 8 |
| Q89598505 | Candidate SNP Markers of Atherogenesis Significantly Shifting the Affinity of TATA-Binding Protein for Human Gene Promoters show stabilizing Natural Selection as a Sum of Neutral Drift Accelerating Atherogenesis and Directional Natural Selection Slo |
| Q36247353 | Ferulic Acid Exerts Anti-Angiogenic and Anti-Tumor Activity by Targeting Fibroblast Growth Factor Receptor 1-Mediated Angiogenesis |
| Q27011668 | Fibroblast growth factor signaling in the vasculature |
| Q36407662 | The Relationship between Proliferative Scars and Endothelial Function in Surgically Revascularized Patients. |
Search more.